Alexandria Real Estate Faces Class Action Lawsuit Due to Poor Q3 Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 24 2025
0mins
Source: Globenewswire
- Lawsuit Notification: Investors must file lead plaintiff applications by January 26, 2026, against Alexandria Real Estate for failing to disclose material information during the class period from January 27 to October 27, 2025, violating federal securities laws.
- Financial Setback: The Q3 2025 financial results revealed a cut in FFO guidance due to lower occupancy rates and slower leasing activity, resulting in a significant real estate impairment charge of $323.9 million, which raises concerns about the company's financial stability.
- Stock Price Plunge: Following the earnings report on October 27, 2025, Alexandria's stock price dropped from $77.87 to $62.94, a nearly 19% decline in just one day, indicating strong market apprehension regarding its financial outlook.
- Legal Implications: The case is pending in the Central District Court of California, and failure to apply in time will forfeit investors' rights to recover economic losses, highlighting the critical nature of legal proceedings for investor protection.
Analyst Views on ARE
Wall Street analysts forecast ARE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARE is 64.78 USD with a low forecast of 30.00 USD and a high forecast of 104.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
2 Buy
9 Hold
1 Sell
Hold
Current: 49.170
Low
30.00
Averages
64.78
High
104.00
Current: 49.170
Low
30.00
Averages
64.78
High
104.00
About ARE
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
